Global Perspective on Lung Cancer in 2019 and Beyond

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment. Topics include: clinical decision making, to what extent will emerging data affect ongoing research, development of new compounds, and future treatment paradigms.

Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey Langer, MD, FACP

University of Pennsylvania, US

Look Inside This Report

Download a sample of this report and start discovering the insights

Key Takeaways and Strategic Insights

The report includes recommendations and key takeaways on

  • Immunotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Immunotherapy in Potentially Curable (Stage I-III) NSCLC
  • Evolving Standards in Small Cell Lung Cancer (SCLC)
  • Extending Outcomes in EGFR-Mutated NSCLC
  • Targeting ALK and Other Oncogenic Drivers

Faculty Members

Benjamin Besse, MD, PhD
Gustave Roussy

Jamie Chaft, MD
Memorial Sloan Kettering Cancer Center

Enriqueta Felip, MD, PhD
Vall d’Hebron University Hospital

Roy Herbst, MD, PhD
Yale Cancer Center

Keith M. Kerr, FRCPath
Aberdeen University Medical School

Solange Peters, MD, PhD
Lausanne University Hospital

Ignacio I. Wistuba, MD
MD Anderson Cancer Center

Antoinette Wozniak, MD
University of Pittsburgh Medical Center

Explore Available and Upcoming Insight Reports

View Reports